MOSS Stock Overview
Manufactures and sells personalized health, anti-aging, and wellness products in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Moss Genomics Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.15 |
| 52 Week Low | CA$0.005 |
| Beta | 0 |
| 1 Month Change | -80.00% |
| 3 Month Change | -50.00% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -97.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| MOSS | CA Personal Products | CA Market | |
|---|---|---|---|
| 7D | -66.7% | 1.5% | -2.6% |
| 1Y | n/a | 5.0% | 15.2% |
Return vs Industry: Insufficient data to determine how MOSS performed against the Canadian Personal Products industry.
Return vs Market: Insufficient data to determine how MOSS performed against the Canadian Market.
Price Volatility
| MOSS volatility | |
|---|---|
| MOSS Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 10.9% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CA Market | 17.3% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: MOSS's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine MOSS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Karl Cahill | www.mossgenomics.com |
Moss Genomics Inc. manufactures and sells personalized health, anti-aging, and wellness products in Canada. The company was formerly known as Nou Camp Capital Corp. and changed its name to Moss Genomics Inc. in July 2021. Moss Genomics Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.
Moss Genomics Inc. Fundamentals Summary
| MOSS fundamental statistics | |
|---|---|
| Market cap | CA$223.64k |
| Earnings (TTM) | CA$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MOSS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MOSS income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$0 |
| Earnings | CA$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MOSS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 15:53 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Moss Genomics Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|